Logo image of VER-H.CA

VERISANTE TECHNOLOGY INC (VER-H.CA) Stock Fundamental Analysis

TSX-V:VER-H - TSX Venture Exchange - CA92346G2036 - Common Stock - Currency: CAD

0.02  +0.01 (+33.33%)

Fundamental Rating

0

Taking everything into account, VER-H scores 0 out of 10 in our fundamental rating. VER-H was compared to 14 industry peers in the Health Care Equipment & Supplies industry. VER-H has a bad profitability rating. Also its financial health evaluation is rather negative. VER-H does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VER-H had negative earnings in the past year.
VER-H had a negative operating cash flow in the past year.
VER-H had negative earnings in 4 of the past 5 years.
VER-H had a negative operating cash flow in each of the past 5 years.
VER-H.CA Yearly Net Income VS EBIT VS OCF VS FCFVER-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M

1.2 Ratios

The Return On Assets of VER-H (-972.03%) is worse than 92.86% of its industry peers.
Industry RankSector Rank
ROA -972.03%
ROE N/A
ROIC N/A
ROA(3y)44.81%
ROA(5y)-78.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VER-H.CA Yearly ROA, ROE, ROICVER-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

1.3 Margins

VER-H does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VER-H.CA Yearly Profit, Operating, Gross MarginsVER-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, VER-H has more shares outstanding
The number of shares outstanding for VER-H has been increased compared to 5 years ago.
The debt/assets ratio for VER-H is higher compared to a year ago.
VER-H.CA Yearly Shares OutstandingVER-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
VER-H.CA Yearly Total Debt VS Total AssetsVER-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

Based on the Altman-Z score of -2891.40, we must say that VER-H is in the distress zone and has some risk of bankruptcy.
VER-H has a worse Altman-Z score (-2891.40) than 92.86% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2891.4
ROIC/WACCN/A
WACCN/A
VER-H.CA Yearly LT Debt VS Equity VS FCFVER-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M

2.3 Liquidity

VER-H has a Current Ratio of 0.70. This is a bad value and indicates that VER-H is not financially healthy enough and could expect problems in meeting its short term obligations.
VER-H has a Current ratio (0.70) which is in line with its industry peers.
VER-H has a Quick Ratio of 0.70. This is a bad value and indicates that VER-H is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of VER-H (0.70) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.7
VER-H.CA Yearly Current Assets VS Current LiabilitesVER-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

VER-H shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.17%.
EPS 1Y (TTM)-4.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VER-H.CA Yearly Revenue VS EstimatesVER-H.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 50K 100K 150K 200K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
VER-H.CA Price Earnings VS Forward Price EarningsVER-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VER-H.CA Per share dataVER-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 0 0 0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VER-H does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VERISANTE TECHNOLOGY INC

TSX-V:VER-H (8/5/2025, 7:00:00 PM)

0.02

+0.01 (+33.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners76.06%
Ins Owner ChangeN/A
Market Cap878.80K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -972.03%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)44.81%
ROA(5y)-78.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.7
Quick Ratio 0.7
Altman-Z -2891.4
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y74.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.71%
OCF growth 3YN/A
OCF growth 5YN/A